Pilot study: Dystrophic pathways in human hair follicles after chemotherapy

Pilot study: Dystrophic pathways in human hair follicles after chemotherapy - Path-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40394

Enrollment

Registered

2013-11-15

Start date

2013-12-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia Hair loss

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Female patients with breast cancer - Age 18 years or more - Written informed consent - Indication for at leaust one cycle of intravenous administered Docetaxel-Adriamycin-Cyclofosfamide (TAC), Fluorouracil-Epirubicin-Cyclophosphamide (FEC) or Adriamycin-Cyclophosphamide (AC).

Exclusion criteria

Exclusion criteria: - Use of scalp cooling

Design outcomes

Primary

Measure	Time frame
Expression of damage-response pathways	—

Countries

Netherlands

Outcome results